AUTOMATED ENDOSCOPE REPROCESSORS MARKET ANALYSIS

Computerized/Automated Endoscope Reprocessors are important medical devices broadly utilized as a healthcare setting to reprocess endoscopes, for example, duodenoscopes, and endoscope accessories, to sterilize them while reprocessing. Automated endoscope reprocessors are intended to kill microorganisms in or on reusable endoscopes by uncovering their outside surfaces and inside channels to compound

The global automated endoscope reprocessors market is estimated to account for US$ 424.8 Mn in terms of value and is expected to reach US$ 706.3 Mn by the end of 2027.

Global Automated Endoscope Reprocessors Market: Drivers

Shift towards value-based healthcare model is expected to propel growth of the global automated endoscope reprocessors market over the forecast period. Automated endoscope reprocessors play a critical role in healthcare set up, as they are used in everyday healthcare practice and for all age groups. Government and regulatory bodies of various countries are adopting various cost-containment measures to reduce the healthcare burden, especially in developed economies. It is driven by various measures taken by governments, medical device providers, insurance payers and manufacturers, which include outcome-based pricing, profit and risk sharing, price control and competitive tendering.

Moreover, increasing number of infection rate and hospital-acquired infections (HAIs) is also expected to aid in growth of the market. Automated endoscope reprocessors help reduce incidence of infections (endogenous or exogenous) and thus, demand for the same is expected to gain traction over the forecast period.

Single Basin AER held dominant position in the global automated endoscope reprocessors market in 2019, accounting for 50.02% share in terms of value, followed by Dual Basin AER.

Figure 1. Global Automated Endoscope Reprocessors Market Share (%), by Value, by Product Type, 2019

To learn more about this report, Request sample copy

Global Automated Endoscope Reprocessors Market: Restraints

Risks of infection after endoscopic reprocessing procedures is expected to hinder growth of the global automated endoscope reprocessors market. E-coli microscopic organisms can be passed among patients by means of unclean endoscopes, which can bring about an intense disease episode. Automated endoscope reprocessors market is experiencing many issues related to infection control, adaptable endoscopes may turn out to be intensely debased with blood, emissions, and microorganisms amid utilize. These instruments are hard to clean and sanitize and simple to harm in view of their mind boggling plan, with thin lumens and numerous inside channels.

Moreover, development of custom ultrasonics automated endoscope reprocessors result into significant negative impact on patient safety. Contaminations may pass starting with one patient then onto the next because of absence of accomplishment in totally annihilating microbes and past disease from reusable endoscopes. Such scenario is also expected to hinder the market growth.

Global Automated Endoscope Reprocessors Market: Opportunities 

Increasing number of emergency surgeries is expected to offer lucrative growth opportunities for players in the global automated endoscope reprocessors market. For instance, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, admissions for emergency surgery increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals and by 5.1% in private hospitals in Australia.

Moreover, shift towards advanced automated endoscope reprocessors compared to conventional systems is also expected to aid in growth of the market. Over the last few years, companies have been focusing on development of newer automated endoscope reprocessors to target a range of end consumers including hospitals and specialty clinics. New automated endoscope reprocessors are known for full cleaning of endoscopes by eradicating infection transmission and cross-contamination.

The global automated endoscope reprocessors market was valued at US$ 394.8 Mn in 2019 and is forecast to reach a value of US$ 706.3 Mn by 2027 at a CAGR of 7.4% between 2020 and 2027.

Figure 2. Global Automated Endoscope Reprocessors Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

To learn more about this report, Request sample copy

Market Trends/Key Takeaways

Approval and launch of new devices is expected to propel growth of the global automated endoscope reprocessors market. For instance, in April 2018, The U.S. Food and Drug Administration announced that Custom Ultrasonics completed validation testing of its System Plus automated endoscope reprocessors, and that the devices are cleared for the reprocessing of certain duodenoscopes.

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in October 2019, Cantel Medical Corp. acquired Hu-Friedy Mfg. Co LLC, a manufacturer of instruments and instrument reprocessing workflow systems.

Global Automated Endoscope Reprocessors Market: Competitive Landscape

Major players operating in the global automated endoscope reprocessors market include, STERIS Plc., Olympus Corporation, Laboratory Anios, Hoya Corporation, Getinge AB, Metull Zug AG, Steelco S.p.A., Cantel Medical Corp., Advanced Sterilization Products, Custom Ultrasonics, and Johnson & Johnson.

Global Automated Endoscope Reprocessors Market: Key Developments

Major players in the market are focused on approval of new products to expand their product portfolio. For instance, in April 2019, Advanced Sterilization Products received 510(k) clearance from the U.S. Food and Drug Administration for the ASP AEROFLEX Automatic Endoscope Reprocessor.

Major players in the market are also focused on launching new products to expand their product portfolio. For instance, in October 2018, Olympus Corporation launched its OER-Mini tabletop endoscope reprocessor for ENT.